Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T-cell receptor (TCR) recognizing Fel d 1–derived epitopes is a primary mediator of the allergic immune response to cats. Fel d 1 is a secretoglobin and the dominant allergen in feline dander, recognized by over 90% of cat-allergic individuals (Grönlund et al., 2010). These TCRs, typically found on CD4+ T-helper cells, recognize specific Fel d 1 peptide fragments presented by MHC class II molecules (Archila et al., 2015). This interaction initiates a Th2-biased inflammatory cascade, characterized by the secretion of cytokines like IL-4 and IL-13, which drive IgE production and allergic symptoms (Larche, 2007). Therapeutic interventions, such as peptide-based immuno-therapeutics (e.g., Cat-PAD), target these TCRs by providing short, non-IgE-binding epitopes to induce T-cell anergy or promote regulatory T-cell (Treg) differentiation (Patel et al., 2013). Successful modulation of these TCR-mediated pathways leads to long-term desensitization and reduced clinical reactivity to cat allergens (Worm et al., 2011).
Induction of immunological tolerance through T-cell anergy, deletion, or the promotion of regulatory T-cells (Tregs) following repeated exposure to specific Fel d 1 epitopes (Larche, 2007; Patel et al., 2013).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor recognizing Fel d 1–derived epitopes (TCR-Fel d 1).